Home Page

Developing a Needle-Free Technology to Enhance the Dental Experience
St. Renatus, LLC, was founded to develop a revolutionary innovation –
the world’s first dental anesthetic administered through the nasal cavity.
This Investigative New Drug (IND) has completed the U.S. Food and Drug Administration (FDA) Phase 3 Clinical Trials and has a goal of gaining FDA approval.

> Learn More